| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Qvt Financial LP | 65.79M (16.37%) | 0.00 Increased by 0.00% | Mar 31, 25 |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 61.85M (15.39%) | -204.82K Decreased by -0.33% | Mar 31, 25 |
| 3 | FMR Inc | 51.67M (12.86%) | 2.36M Increased by +4.58% | Mar 31, 25 |
| 4 | Viking Global Investors LP | 46.01M (11.45%) | -1.80M Decreased by -3.90% | Mar 31, 25 |
| 5 | BlackRock Inc | 41.66M (10.37%) | -498.04K Decreased by -1.20% | Mar 31, 25 |
| 6 | Vanguard Group Inc | 40.77M (10.15%) | -3.32M Decreased by -8.14% | Mar 31, 25 |
| 7 | Morgan Stanley - Brokerage Accounts | 35.93M (8.94%) | 1.31M Increased by +3.65% | Mar 31, 25 |
| 8 | State Street Corp | 18.86M (4.69%) | -1.94M Decreased by -10.29% | Mar 31, 25 |
| 9 | Rubric Capital Management LP | 17.77M (4.42%) | -2.23M Decreased by -12.57% | Mar 31, 25 |
| 10 | State Street Corporation | 17.15M (4.27%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (3.39%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.48M (3.11%) | 0.00 Increased by 0.00% | Mar 31, 25 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (2.65%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 10.14M (2.52%) | -31.50K Decreased by -0.31% | Mar 31, 25 |
| 15 | Amvescap Plc. | 9.88M (2.46%) | 365.47K Increased by +3.70% | Mar 31, 25 |
| 16 | Geode Capital Management, LLC | 7.97M (1.98%) | 195.55K Increased by +2.45% | Mar 31, 25 |
| 17 | Baker Bros Advisors LP | 7.41M (1.85%) | -179.19K Decreased by -2.42% | Mar 31, 24 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (1.83%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | UBS Group AG | 6.80M (1.69%) | 1.51M Increased by +22.18% | Mar 31, 25 |
| 20 | Citadel Advisors Llc | 5.93M (1.48%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 23.75M (5.91%) | 149.50K Increased by +0.63% | Apr 30, 25 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (5.26%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 16.90M (4.20%) | 212.00K Increased by +1.25% | Apr 30, 25 |
| 4 | Vanguard US Total Market Shares ETF | 14.26M (3.55%) | 14.26M Increased by +100.00% | Sep 30, 24 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 13.76M (3.43%) | 11.18K Increased by +0.08% | May 31, 25 |
| 6 | iShares Core S&P Mid-Cap ETF | 13.68M (3.40%) | 0.00 Increased by 0.00% | May 31, 25 |
| 7 | Fidelity® Growth Company | 10.84M (2.70%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Small Cap Index | 10.80M (2.69%) | 54.34K Increased by +0.50% | May 31, 25 |
| 9 | Vanguard Health Care Inv | 9.57M (2.38%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 10 | Vanguard Institutional Extnd Mkt Idx Tr | 6.56M (1.63%) | 45.13K Increased by +0.69% | May 31, 25 |
| 11 | Invesco S&P MidCap Quality ETF | 6.02M (1.50%) | 0.00 Increased by 0.00% | May 30, 25 |
| 12 | Vanguard Small Cap Growth Index Inv | 5.92M (1.47%) | -59.40K Decreased by -1.00% | May 31, 25 |
| 13 | SPDR® S&P Biotech ETF | 5.70M (1.42%) | 33.74K Increased by +0.59% | May 31, 25 |
| 14 | Fidelity Growth Company K6 | 5.30M (1.32%) | 30.90K Increased by +0.58% | Apr 30, 25 |
| 15 | T. Rowe Price Mid-Cap Growth | 5.25M (1.31%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 16 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.31%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 17 | Fidelity Series Growth Company | 5.10M (1.27%) | 734.00K Increased by +14.40% | Apr 30, 25 |
| 18 | Fidelity® Select Biotechnology | 4.60M (1.15%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 19 | MS INVF US Growth I | 4.03M (1.00%) | 0.00 Increased by 0.00% | Mar 31, 25 |
| 20 | MS INVF US Advantage I | 3.77M (0.94%) | 0.00 Increased by 0.00% | Mar 31, 25 |